Environmental carcinogenesis

The Molecular Basis of Cancer

Volumn , Issue , 2008, Pages 91-113

  Abel, Erika L ^a   DiGiovanni, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70249122521     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141603703-3.10007-X     Document Type: Chapter

References (100)

1. Dipple A Polycyclic aromatic hydrocarbon carcinogenesis. ACS Symposium Series 1985, 283. American Chemical Society, Philadelphia. R.G. Harvey (Ed.).
2. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993, 85:1819.
3. Chang S, Bondy ML, Gurney JG. Cancer epidemiology. UICC Manual of Clinical Oncology 2004, John Wiley & Sons, Hoboken, NJ. R.E. Pollock (Ed.).
4. Doll R, Peto R The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981, 66:1191.
5. Hecht SS Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999, 91:1194.
6. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625.
7. Calle EE, Kaaks R Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004, 4:579.
8. Montesano R, Hall J Environmental causes of human cancers. Eur J Cancer 2001, 37(Suppl 8):S67.
9. Garte SJ Ionizing radiation as a carcinogen. Comprehensive Toxicology 1997, Vol. 12. Elsevier Science, New York. G. Sipes, C.A. McQueen, A.J. Gandolfi (Eds.).
10. Delclos KB, Kadlubar FF Carcinogenic aromatic amines and amides. Comprehensive Toxicology 1997, Vol. 12:141-170. Elsevier Science, New York. G. Sipes, C.A. McQueen, A.J. Gandolfi (Eds.).
11. Wagoner JK Toxicity of vinyl chloride and poly(vinyl chloride): a critical review. Environ Health Perspect 1983, 52:61.
12. Sipes G, McQueen CA, Gandolfi AJ Comprehensive Toxicology 1997, Vol. 12. Elsevier Science, New York.
13. Pitot HCI, Dragan YP Chemical carcinogenesis. Casarett & Doull's ToxicologyThe Basic Science of Poisons 1996, 201-267. McGraw-Hill, New York. C.D. Klaassen (Ed.).
14. Hussein MR Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol 2005, 32:191.
15. IARC monographs on the evaluation of carcinogenic risks to humans: solar and ultraviolet radiation. IARC Monogr Eval Carcinog Risks Hum 1992, 55:1.
16. de Laat A, van Tilburg M, van der Leun JC, et al. Cell cycle kinetics following UVA irradiation in comparison to UVB and UVC irradiation. Photochem Photobiol 1996, 63:492.
17. Anderson RR, Parrish JA The optics of human skin. J Invest Dermatol 1981, 77:13.
18. Wakeford R The cancer epidemiology of radiation. Oncogene 2004, 23:6404.
19. Little JB Radiation carcinogenesis. Carcinogenesis 2000, 21:397.
20. Little JB What are the risks of low-level exposure to alpha radiation from radon?. Proc Natl Acad Sci U S A 1997, 94:5996.
21. Duarte-Davidson R, Courage C, Rushton L, et al. Benzene in the environment: an assessment of the potential risks to the health of the population. Occup Environ Med 2001, 58:2.
22. Smith MT The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ Health Perspect 1996, 104(Suppl 6):1219.
23. Xue W, Warshawsky D Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 2005, 206:73.
24. Rubin H Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis 2001, 22:1903.
25. Guengerich FP, Johnson WW, Shimada T, et al. Activation and detoxication of aflatoxin B1. Mutat Res 1998, 402:121.
26. Smela ME, Currier SS, Bailey EA, et al. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. Carcinogenesis 2001, 22:535.
27. Kew MC Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int 2003, 23:405.
28. Golka K, Kopps S, Myslak ZW Carcinogenicity of azo colorants: influence of solubility and bioavailability. Toxicol Lett 2002, 151:203.
29. Zenser TV, Lakshmi VM, Hsu FF, et al. Metabolism of N-acetylbenzidine and initiation of bladder cancer. Mutat Res 2002, 506-507:29.
30. Whysner J, Verna L, Williams GM Benzidine mechanistic data and risk assessment: species- and organ-specific metabolic activation. Pharmacol Ther 1996, 71:107.
31. Knekt P, Jarvinen R, Dich J, et al. Risk of colorectal and other gastro-intestinal cancers after exposure to nitrate, nitrite and N-nitroso compounds: a follow-up study. Int J Cancer 1999, 80:852.
32. Cross AJ, Sinha R Meat-related mutagens/carcinogens in the etiology of colorectal cancer. Environ Mol Mutagen 2004, 44:44.
33. Hecht SS Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998, 11:559.
34. Kuschner M The carcinogenicity of beryllium. Environ Health Perspect 1981, 40:101.
35. Gordon T, Bowser D Beryllium: genotoxicity and carcinogenicity. Mutat Res 2003, 533:99.
36. Waisberg M, Joseph P, Hale B, et al. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 2003, 192:95.
37. Waalkes MP Cadmium carcinogenesis. Mutat Res 2003, 533:107.
38. Tapio S, Grosche B Arsenic in the aetiology of cancer. Mutat Res 2006, 612:215.
39. IARC Monogr Eval Carcinog Risks Hum 2004, 84:1. Some drinking-water disinfectants and contaminants, including arsenic.
40. Huang C, Ke Q, Costa M, et al. Molecular mechanisms of arsenic carcinogenesis. Mol Cell Biochem 2004, 255:57.
41. O'Brien TJ, Ceryak S, Patierno SR Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res 2003, 533:3.
42. Ding M, Shi X Molecular mechanisms of Cr(VI)-induced carcinogenesis. Mol Cell Biochem 2002, 234-235:293.
43. Robinson BW, Musk AW, Lake RA Malignant mesothelioma. Lancet 2005, 366:397.
44. Barrett JC, Lamb PW, Wiseman RW Multiple mechanisms for the carcinogenic effects of asbestos and other mineral fibers. Environ Health Perspect 1989, 81:81.
45. Amre DK, Infante-Rivard C, Dufresne A, et al. Case-control study of lung cancer among sugar cane farmers in India. Occup Environ Med 1999, 56:548.
46. Dunn BK, Wickerham DL, Ford LG Prevention of hormone-related cancers: breast cancer. J Clin Oncol 2005, 23:357.
47. Parnes HL, Thompson IM, Ford LG Prevention of hormone-related cancers: prostate cancer. J Clin Oncol 2005, 23:368.
48. Russo J, Russo IH Biological and molecular bases of mammary carcinogenesis. Lab Invest 1987, 57:112.
49. Slaga TJ Mechanisms of Tumor Promotion 1983, CRC Press, Boca Raton, FL.
50. DiGiovanni J Multistage carcinogenesis in mouse skin. Pharmacol Ther 1992, 54:63.
51. Brookes P, Lawley PD Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to deoxyribonucleic acid. Nature 1964, 202:781.
52. Bailleul B, Brown K, Ramsden M, et al. Chemical induction of oncogene mutations and growth factor activity in mouse skin carcinogenesis. Environ Health Perspect 1989, 81:23.
53. Hennings H, Glick AB, Greenhalgh DA, et al. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis. Proc Soc Exp Biol Med 1993, 202:1.
54. Yuspa SH The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis: thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res 1994, 54:1178.
55. Wilker E, Lu J, Rho O, et al. Role of PI3K/Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion. Mol Carcinog 2005, 44:137.
56. Chan KS, Sano S, Kiguchi K, et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 2004, 114:720.
57. Slaga TJ, Budunova IV, Gimenez-Conti IB, et al. The mouse skin carcinogenesis model. J Investig Dermatol Symp Proc 1996, 1:151.
58. Hahn WC, Weinberg RA Modelling the molecular circuitry of cancer. Nat Rev Cancer 2002, 2:331.
59. Kinzler KW, Vogelstein B Lessons from hereditary colorectal cancer. Cell 1996, 87:159.
60. Wistuba, II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999, 18:643.
61. Hussain SP, Harris CC p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat Res 1999, 428:23.
62. Denissenko MF, Pao A, Tang M, et al. Preferential formation of benzo(a)pyrene adducts at lung cancer mutational hotspots in p53. Science 1996, 274:430.
63. Kelada SN, Eaton DL, Wang SS, et al. The role of genetic polymorphisms in environmental health. Environ Health Perspect 2003, 111:1055.
64. Nelson DR, Koymans L, Kamataki T, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996, 6:1.
65. Eaton DL, Bammler TK Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 1999, 49:156.
66. Van Ness KP, McHugh TE, Bammler TK, et al. Identification of amino acid residues essential for high aflatoxin B1-8,9-epoxide conjugation activity in alpha class glutathione S-transferases through site-directed mutagenesis. Toxicol Appl Pharmacol 1998, 152:166.
67. Whysner J, Conaway CC, Verna L, et al. Vinyl chloride mechanistic data and risk assessment: DNA reactivity and cross-species quantitative risk extrapolation. Pharmacol Ther 1996, 71:7.
68. Ozawa N, Guengerich FP Evidence for formation of an S-(2-(N7-guanyl)ethyl)glutathione adduct in glutathione-mediated binding of the carcinogen 1,2-dibromoethane to DNA. Proc Natl Acad Sci U S A 1983, 80:5266.
69. Gonzalez FJ The role of carcinogen-metabolizing enzyme polymorphisms in cancer susceptibility. Reprod Toxicol 1997, 11:397.
70. McIlwain CC, Townsend DM, Tew KD Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006, 25:1639.
71. McWilliams JE, Sanderson BJ, Harris EL, et al. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 1995, 4:589.
72. Martinez C, Martin F, Fernandez JM, et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics 2006, 7:711.
73. Strange RC, Fryer AA The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ 1999, 231.
74. Coles B, Nowell SA, MacLeod SL, et al. The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk. Mutat Res 2001, 482:3.
75. Geisler SA, Olshan AF GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol 2001, 154:95.
76. Maugard CM, Charrier J, Pitard A, et al. Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier. Int J Cancer 2001, 91:334.
77. Rodriguez-Antona C, Ingelman-Sundberg M Cytochrome P450 pharmacogenetics and cancer. Oncogene 2006, 25:1679.
78. Li G, Liu Z, Sturgis EM, et al. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 2005, 14:1034.
79. Kleiner HE, Vulimiri SV, Hatten WB, et al. Role of cytochrome p4501 family members in the metabolic activation of polycyclic aromatic hydrocarbons in mouse epidermis. Chem Res Toxicol 2004, 17:1667.
80. Bartsch H, Nair U, Risch A, et al. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000, 9:3.
81. Song N, Tan W, Xing D, et al. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis 2001, 22:11.
82. Vineis P, Veglia F, Benhamou S, et al. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 2003, 104:650.
83. Hein DW N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol Lett 2000, 112-113:349.
84. Hein DW N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene 2006, 25:1649.
85. Wood RD, Mitchell M, Lindahl T Human DNA repair genes, 2005. Mutat Res 2005, 577:275.
86. Goode EL, Ulrich CM, Potter JD Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002, 11:1513.
87. de Boer JG Polymorphisms in DNA repair and environmental interactions. Mutat Res 2002, 509:201.
88. Hu Z, Wei Q, Wang X, et al. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer 2004, 46:1.
89. Hung RJ, Hall J, Brennan P, et al. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 2005, 162:925.
90. Sturgis EM, Castillo EJ, Li L, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999, 20:2125.
91. Hao B, Miao X, Li Y, et al. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene 2006, 25:3613.
92. Hu Z, Ma H, Chen F, et al. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005, 14:1810.
93. Mortelmans K, Zeiger E The Ames Salmonella/microsome mutagenicity assay. Mutat Res 2000, 455:29.
94. Silva Lima B, Van der Laan JW Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard. Regul Toxicol Pharmacol 2000, 32:1350.
95. Lollini PL, Cavallo F, Nanni P, et al. Vaccines for tumour prevention. Nat Rev Cancer 2006, 6:204.
96. Pool-Zobel B, Veeriah S, Bohmer FD Modulation of xenobiotic metabolising enzymes by anticarcinogens: focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res 2005, 591:74.
97. Kensler TW Chemoprevention by inducers of carcinogen detoxication enzymes. Environ Health Perspect 1997, 105(Suppl 4):965.
98. Hursting SD, Slaga TJ, Fischer SM, et al. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst 1999, 91:215.
99. Neill MG, Fleshner NE An update on chemoprevention strategies in prostate cancer for 2006. Curr Opin Urol 2006, 16:132.
100. Perkins AS, Stern DF Molecular Biology of Cancer. Oncogenes. Cancer: Principles & Practice of Oncology 1997, Lippincott-Raven Publishers, Philadelphia. 5th Ed. V.T. DeVita, S. Hellman, S.A. Rosenbert (Eds.).